Meghan Roswick to Speak at Feel the Beat 2014
The Todd and Karen Wanek Family Program for HLHS is honored to announce that Meghan Roswick will be a featured guest speaker at Feel the Beat 2014 to be held on Saturday, Nov. 8, at Mayo Clinic in Rochester. Meghan is a 22-year-old HLHS survivor who has a passion for life. You can catch her pushing the limits either on the ski slopes or in the skate park. Recently nominated as one of the Women Who Inspire, Meghan will share her inspiring journey with HLHS and the hope that her future brings. You won't want to miss this! You can hear from Meghan below and follow her on Facebook at Meghan Roswick-HLHS.
My name is Meghan Roswick, and I am a 22-year-old HLHS survivor. I underwent four open-heart surgeries by the time I was two and a half, performed by Dr. Marshall Jacobs at Children’s Hospital of Philadelphia. My passion for HLHS research and education stems from my love of science but even more so from my hope to extend my life’s span. Learning about Mayo Clinic’s research has shed new light on the strong progressive curve that medicine has taken and the direct impact that it has, and will have on my life for years to come. It is easy for me, and I am certain for other families, to get distracted by the emotional toll HLHS has taken on us. However, after I discovered the Todd and Karen Wanek Family Program for HLHS and all of the research being done to help HLHS patients, I have been given new perspective, and look forward to seeing what the future has in store for young HLHS patients, as well as patients who are getting older. I am honored to be attending and speaking this November, and I am thrilled to get to meet individuals and families in my position and share the experience of finding out what the future might hold for us. I hope to see you there!
Click here to learn more about Meghan.
The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science, to diagnostic imaging to regenerative therapies.